medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2015, Number 614

<< Back Next >>

Rev Med Cos Cen 2015; 72 (614)

Cese del fumado: terapias no farmacológicas

Calvo FS, Sanabria CM, Gálvez LM

Language: Spanish
References: 12
Page: 111-116
PDF size: 72.30 Kb.


ABSTRACT

There is consistent evidence that the individual council increases the probability to cease smoking compared to the intensive support. Ever more if this council is personalized, in periodical seasons (6 to 8 ideally) of 31 to 90 minutes, given by health personnel and especially by doctors. If it is possible it's got to be proactive. It’s been seen that even if the nicotine replacement added to the individual therapy augments the ceasing of smoking, the augmentation is not relevant compared to the individual therapy alone. And this one being available ubiquitously is the treatment by excellence to quit smoking (Evidence type A).


REFERENCES

  1. Becerra, N. Cañón, M. Vivas, J. (2010). Terapia farmacológica para el abandono del tabaquismo. Universidad médica de Bogotá, 51 (2), 167-183.

  2. Brittany M. Brothers,B; Borrelli B. Motivating Latino Smokers to Quit: Does Type of Social Support Matter? American Journal of Health Promotion May/June 2011, Vol. 25, No. 5 Supplement

  3. Hays J, E. J. (2010). Adverse Effects and Tolerability of Medications for the Treatment of Tobacco Use and Dependence. Drugs , 70 (18), 2357 - 2372.

  4. Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation (Review). Published by JohnWiley & Sons, Ltd.The Cochrane Library 2008, Issue 4

  5. Mayer, C. et al. Smoking Relapse Prevention Programs and Factors That Predict Abstinence: A Controlled Study Comparing the Efficacy of Workplace Group Counselling and Proactive Phone Counselling. Journal Of Smoking Cessation. 2010; 5(1), 83–94.

  6. Niaura, R. Nonpharmacologic Therapy for Smoking Cessation: Characteristics and Efficacy of Current Approaches. The American Journal of Medicine (2008) Vol 121 (4A), S11–S19

  7. Otero, M°J. (2003). Capítulo VIII: Efectos adversos del tratamiento farmacológico del tabaquismo. En: Barrueco, M; et al. Manual de prevención y tratamiento del tabaquismo. Madrid, ERGON, p. 241-268

  8. Pérez, A; Clemente, M°L.; Herrero, I. (2003) Otras alternativas terapéuticas de utilidad en la deshabituación tabáquica. En: Barrueco, M; et all. Manual de prevención y tratamiento del tabaquismo. Madrid, ERGON, p. 211-240.

  9. ProvidersCancer Epidemiol Biomarkers Prev 2004;13:2012- 2022.

  10. Sansores RH, Pérez-Bautista O, Ramírez-Venegas A. Guías de atención médica para dejar de fumar. Una propuesta para Latinoamérica. Salud Publica Mex 2010;52 supl 2:S355-S365

  11. Sheinfeld S.& J. Heck. Meta- Analysis of the Efficacy of Tobacco Counseling by Health Care

  12. WHO. WHO European Strategy for Smoking Cessation Policy. Revision 2004




2020     |     www.medigraphic.com